N-Nitroso Edoxaban Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs.N-Nitroso Edoxaban Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 1 chemically represented as 5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridin-2-amine.Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 1 .We supply N-Nitroso Edoxaban Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142035 |
| CAS No | NA |
| Mol.F. | C16H18N2O3 |
| Mol.Wt. | 286.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142036 |
| CAS No | NA |
| Mol.F. | C19H21FN2O2 |
| Mol.Wt. | 328.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142037 |
| CAS No | NA |
| Mol.F. | C22H25FN2O5 |
| Mol.Wt. | 416.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142038 |
| CAS No | NA |
| Mol.F. | C22H25ClF2N2O5 |
| Mol.Wt. | 434.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142039 |
| CAS No | NA |
| Mol.F. | C28H32F2N2O11 |
| Mol.Wt. | 610.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142040 |
| CAS No | NA |
| Mol.F. | C22H24F2N2O6 |
| Mol.Wt. | 450.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142041 |
| CAS No | NA |
| Mol.F. | C22H24F2N2O5 |
| Mol.Wt. | 434.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142042 |
| CAS No | NA |
| Mol.F. | C12H16N2O3 |
| Mol.Wt. | 236.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142043 |
| CAS No | NA |
| Mol.F. | C18H19FN2O3 |
| Mol.Wt. | 330.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142044 |
| CAS No | NA |
| Mol.F. | C8H8ClN7O |
| Mol.Wt. | 253.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142045 |
| CAS No | NA |
| Mol.F. | C6H6N6O2 |
| Mol.Wt. | 194.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142046 |
| CAS No | NA |
| Mol.F. | C17H19N5O10 |
| Mol.Wt. | 453.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142047 |
| CAS No | NA |
| Mol.F. | C11H13N5O7 |
| Mol.Wt. | 327.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142048 |
| CAS No | NA |
| Mol.F. | C10H10N6O8 |
| Mol.Wt. | 342.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142049 |
| CAS No | NA |
| Mol.F. | C16H16N6O11 |
| Mol.Wt. | 468.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142050 |
| CAS No | NA |
| Mol.F. | C6H6N6O3 |
| Mol.Wt. | 210.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |